Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
cao xa tm vi tay tr em
The Phase 2 retatrutide trial (PMID 37366315) reported -24.2% body weight change at the 12 mg weekly dose across 48 weeks
Last reviewed: July 10, 2026 Last updated: July 10, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Possible Benefits Healthy red blood cells Increased energy levels Improved quality of sleep Enhanced mood and brain functioning Healthy cardiovascular systemIf Prescribed Product Purchase Includes: Medication Medical provider consultation Syringes Alcohol Pads Program guide Administration video Administration and Frequency Available in Subcutaneous (SQ) Injections Three (3) times a week
A physician-prescribed GHK-Cu topical formulation from a licensed 503A or 503B compounding pharmacy is the gold standard for skin and hair patients in 2026
US$ 26.03
US$ 26.21
US$ 27.32
